Erythropoietin (EPO) is secreted primarily by the peritubular interstitial cells of the renal cortex. Its production is stimulated by hypoxia through which transcription factor pathway?
- A Hypoxia-inducible factor-1α (HIF-1α) stabilization when prolyl hydroxylase domain (PHD) enzymes are inhibited by low O2 ✓
- B NF-κB pathway activated by inflammatory cytokines
- C STAT3 pathway activated by interleukin-6
- D Wnt/β-catenin pathway in response to haem deficiency
Explanation
Under normoxia, HIF-1α is continuously hydroxylated by PHD enzymes (requiring O2 and α-ketoglutarate as cofactors), targeting it for von Hippel-Lindau (VHL) protein-mediated ubiquitination and proteasomal degradation. In hypoxia, PHD enzymes are inhibited, HIF-1α accumulates, dimerizes with HIF-1β, and translocates to the nucleus to transcribe the EPO gene (among others). PHD inhibitors (roxadustat, daprodustat) exploit this mechanism therapeutically to increase EPO in CKD-related anaemia.
Reference: Guyton & Hall, Textbook of Medical Physiology, 14th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.